Announcement on Change of Accounting Policies
Filed with SSE · · 6 pages · Chinese
North China Pharmaceutical Company Ltd. on 6ix
Earlier from North China Pharmaceutical
- Announcement on the Wholly-owned Subsidiary's Acquisition of the GMP Compliance Certificate Issued by AEMPS of Spain
- Announcement on the Wholly-owned Subsidiary's Passing GMP Compliance Inspection
- Announcement on Expected Increase in Annual Performance for 2024
- Announcement on Receiving the Return of Income from Government Land Purchase, Reserve and Transfer and Signing the Supplementary Contract for Acquisition (Return) of State-owned Land Use Rights of Enterprises and Institutions
- Announcement on Subsidiary's Withdrawal of Drug Registration Application
Later from North China Pharmaceutical
- Announcement on Resolution of the 14th Meeting of the 11th Board of Supervisors
- Announcement on Pledge Release of Some Shareholders' Shares
- Announcement on Lifting the Freeze of Controlling Shareholder's Shares
- Announcement on Obtaining Notice of Approval for Drug Clinical Trials by Subsidiary
- Announcement on Issuance Result of Phase I Short-term Financing Bonds in 2025
Follow North China Pharmaceutical into a list and get an email when it puts out news.
Follow North China Pharmaceutical